Advertisement
Canada markets closed
  • S&P/TSX

    22,284.76
    +41.42 (+0.19%)
     
  • S&P 500

    5,308.15
    +61.47 (+1.17%)
     
  • DOW

    39,908.00
    +349.89 (+0.88%)
     
  • CAD/USD

    0.7350
    +0.0024 (+0.33%)
     
  • CRUDE OIL

    78.84
    +0.82 (+1.05%)
     
  • Bitcoin CAD

    89,912.53
    +6,112.11 (+7.29%)
     
  • CMC Crypto 200

    1,389.63
    +121.68 (+9.60%)
     
  • GOLD FUTURES

    2,393.90
    +34.00 (+1.44%)
     
  • RUSSELL 2000

    2,109.46
    +23.77 (+1.14%)
     
  • 10-Yr Bond

    4.3560
    -0.0890 (-2.00%)
     
  • NASDAQ

    16,742.39
    +231.21 (+1.40%)
     
  • VOLATILITY

    12.45
    -0.97 (-7.23%)
     
  • FTSE

    8,445.80
    +17.67 (+0.21%)
     
  • NIKKEI 225

    38,385.73
    +29.67 (+0.08%)
     
  • CAD/EUR

    0.6752
    -0.0017 (-0.25%)
     

Is It Time To Consider Buying Héroux-Devtek Inc. (TSE:HRX)?

Héroux-Devtek Inc. (TSE:HRX), is not the largest company out there, but it led the TSX gainers with a relatively large price hike in the past couple of weeks. The recent jump in the share price has meant that the company is trading at close to its 52-week high. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, what if the stock is still a bargain? Let’s examine Héroux-Devtek’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.

View our latest analysis for Héroux-Devtek

What's The Opportunity In Héroux-Devtek?

Good news, investors! Héroux-Devtek is still a bargain right now. According to our valuation, the intrinsic value for the stock is CA$30.23, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. However, given that Héroux-Devtek’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.

Can we expect growth from Héroux-Devtek?

earnings-and-revenue-growth
earnings-and-revenue-growth

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. With profit expected to grow by 81% over the next couple of years, the future seems bright for Héroux-Devtek. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What This Means For You

Are you a shareholder? Since HRX is currently undervalued, it may be a great time to increase your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation.

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping an eye on HRX for a while, now might be the time to make a leap. Its buoyant future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy HRX. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed buy.

So while earnings quality is important, it's equally important to consider the risks facing Héroux-Devtek at this point in time. Case in point: We've spotted 1 warning sign for Héroux-Devtek you should be aware of.

If you are no longer interested in Héroux-Devtek, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.